6955.HKEarnings Release财报快讯Media source媒体来源Source link原始来源August 27, 20262026/8/27by InvestLog AIInvestLog AI 整理

Shandong Boan Biotechnology Co., Ltd. (6955.HK) 2026 H1 financial resultsShandong Boan Biotechnology Co., Ltd. (6955.HK) 2026 H1 财报发布

Key Results

Shandong Boan Biotechnology Co., Ltd. reported revenue CN¥233M, net income -CN¥83M.

Period: 2026 H1

Revenue: CN¥233M; YoY: -40.8%

Gross profit: CN¥146M; Gross margin: 62.7%; YoY: -48.3%

Net income: -CN¥83M; Earnings per share: -CN¥0.13; Net margin: -35.6%

Official release: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026

Shandong Boan Biotechnology Co., Ltd. 公布2026 H1财报：营收 CN¥233M，净利润 -CN¥83M。

期间：2026 H1

营收：CN¥233M；同比 -40.8%

毛利润：CN¥146M；毛利率：62.7%；同比 -48.3%

净利润：-CN¥83M；每股收益：-CN¥0.13；净利率：-35.6%

For information only. Not investment advice.内容仅供参考，不构成投资建议。